Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms

Sarah A. Carratt, Garth L. Kong, Brittany M. Curtiss, Zachary Schonrock, Lauren Maloney, Breanna N. Maniaci, Hunter Z. Blaylock, Adrian Baris, Brian J. Druker, Theodore P. Braun, Julia E. Maxson

Blood (2022) 140 (6): 644–658.

https://doi.org/10.1182/blood.2021014777

Published: 2022

Includes: Supplemental data

Journal Articles

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Sarah A Carratt, PhD BS, Theodore P. Braun, MDPhD, Zachary Schonrock, BS, Brittany M. Smith, Daniel J Coleman, PhD, Garth Kong, MS, Joseph Estabrook, MS, Adrian Baris, Lauren Maloney, Julia E. Maxson, PhD

Blood (2020) 136 (Supplement 1): 51–52.

https://doi.org/10.1182/blood-2020-143072

Published: 2020

Journal Articles

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Theodore Braun, MD PhD, Cody Coblentz, Sarah A Carratt, PhD BS, Mariam Okhovat, PhD, Amy Foley, MEng., Zachary Schonrock, BS, Kimberly Nevonen, Rhonda E. Ries, MA, Shannon K. McWeeney, PhD, Claus Nerlov, PhD, Soheil Meshinchi, MD PhD, Lucia Carbone, PhD, Brian J. Druker, Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 543.

https://doi.org/10.1182/blood-2019-124773

Published: 2019

Journal Articles

Single Cell RNA Sequencing Identifies a Crucial Role for ASXL1 in Neutrophil Development

Theodore Braun, MD PhD, Theresa Lusardi, PhD, Trevor Enright, MS, Zachary Schonrock, BS, Cody Coblentz, Hisham Mohamed, PhD, Brian J. Druker, Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 212.

https://doi.org/10.1182/blood-2019-125022

Published: 2019

Journal Articles

SETBP1 Mutations Accelerate NRAS-Mutant Leukemia

Sarah A Carratt, PhD BS, Zachary Schonrock, BS, Theodore Braun, MD PhD, Cody Coblentz, Amy Foley, MEng., Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 1254.

https://doi.org/10.1182/blood-2019-125125

Published: 2019

NARROW

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Single Cell RNA Sequencing Identifies a Crucial Role for ASXL1 in Neutrophil Development

SETBP1 Mutations Accelerate NRAS-Mutant Leukemia

Email alerts

ASH Publications

American Society of Hematology

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Single Cell RNA Sequencing Identifies a Crucial Role for ASXL1 in Neutrophil Development

SETBP1 Mutations Accelerate NRAS-Mutant Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only